The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin in cancer patients.
Masashi Kanai
No relevant relationships to disclose
Yoshihiko Otsuka
No relevant relationships to disclose
Kazunori Otsuka
No relevant relationships to disclose
Takafumi Nishimura
No relevant relationships to disclose
Yukiko Mori
No relevant relationships to disclose
Shigemi Matsumoto
No relevant relationships to disclose
Yuzo Kodama
No relevant relationships to disclose
MIchiya Kawaguchi
No relevant relationships to disclose
Etsuro Hatano
No relevant relationships to disclose
Yoshiki Murakami
No relevant relationships to disclose
Atsushi Imaizumi
No relevant relationships to disclose
Tsutomu Chiba
No relevant relationships to disclose
Jun Nishihira
No relevant relationships to disclose
Hiroyuki Shibata
No relevant relationships to disclose